CIBC Private Wealth Group LLC Has $769,000 Stock Position in Baxter International Inc. (NYSE:BAX)

CIBC Private Wealth Group LLC raised its holdings in Baxter International Inc. (NYSE:BAXFree Report) by 10.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,894 shares of the medical instruments supplier’s stock after buying an additional 1,818 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Baxter International were worth $769,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of BAX. Headinvest LLC acquired a new position in shares of Baxter International during the 3rd quarter valued at $25,000. Bruce G. Allen Investments LLC bought a new position in shares of Baxter International during the 4th quarter worth about $36,000. Turtle Creek Wealth Advisors LLC acquired a new stake in shares of Baxter International in the 4th quarter valued at about $37,000. Hexagon Capital Partners LLC increased its position in Baxter International by 205.4% in the 4th quarter. Hexagon Capital Partners LLC now owns 953 shares of the medical instruments supplier’s stock valued at $37,000 after buying an additional 641 shares in the last quarter. Finally, CKW Financial Group acquired a new position in Baxter International during the 4th quarter worth approximately $43,000. 90.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

BAX has been the subject of several recent research reports. TD Cowen downgraded Baxter International from a “buy” rating to a “hold” rating and set a $40.00 price objective for the company. in a report on Friday, May 10th. Bank of America upped their price objective on shares of Baxter International from $42.00 to $45.00 and gave the stock a “neutral” rating in a report on Tuesday, March 5th. Citigroup reduced their price objective on shares of Baxter International from $44.00 to $38.00 and set a “neutral” rating for the company in a report on Wednesday, May 22nd. The Goldman Sachs Group began coverage on shares of Baxter International in a report on Thursday, May 30th. They issued a “neutral” rating and a $36.00 target price on the stock. Finally, Barclays lifted their price target on Baxter International from $52.00 to $54.00 and gave the company an “overweight” rating in a research note on Monday, February 12th. Nine research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $44.42.

Check Out Our Latest Research Report on BAX

Baxter International Price Performance

Shares of NYSE BAX opened at $32.89 on Tuesday. Baxter International Inc. has a twelve month low of $31.01 and a twelve month high of $50.21. The stock’s 50 day moving average price is $37.48 and its 200-day moving average price is $38.97. The company has a market capitalization of $16.76 billion, a PE ratio of 6.33, a PEG ratio of 1.73 and a beta of 0.61. The company has a quick ratio of 1.01, a current ratio of 1.48 and a debt-to-equity ratio of 1.35.

Baxter International (NYSE:BAXGet Free Report) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.65 earnings per share for the quarter, topping analysts’ consensus estimates of $0.61 by $0.04. Baxter International had a return on equity of 18.47% and a net margin of 17.79%. The firm had revenue of $3.59 billion for the quarter, compared to the consensus estimate of $3.55 billion. During the same quarter in the previous year, the business earned $0.59 EPS. The company’s revenue was down 1.6% compared to the same quarter last year. On average, equities analysts anticipate that Baxter International Inc. will post 2.91 EPS for the current year.

Baxter International Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Friday, May 31st will be paid a $0.29 dividend. The ex-dividend date is Friday, May 31st. This represents a $1.16 dividend on an annualized basis and a dividend yield of 3.53%. Baxter International’s payout ratio is presently 22.31%.

Baxter International Company Profile

(Free Report)

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

Recommended Stories

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAXFree Report).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.